Cite
APA Citation
Duthie, M. S., Frevol, A., Day, T., Coler, R. N., Vergara, J., Rolf, T., Sagawa, Z. K., Marie Beckmann, A., Casper, C., & Reed, S. G. (2020). a phase 1 antigen dose escalation trial to evaluate safety, tolerability and immunogenicity of the leprosy vaccine candidate LepVax (LEP-F1 + GLA–SE) in healthy adults. Vaccine, 38(7), 1700–1707. http://access.bl.uk/ark:/81055/vdc_100099424602.0x000046